Luca Di Noto, PhD
About Luca Di Noto, PhD
Luca Di Noto at Jasper Therapeutics
Luca Di Noto, Ph.D., currently serves as the Senior Vice President of Technical Operations at Jasper Therapeutics. Since joining the company in 2020 as Vice President of Technical Operations, he has contributed significantly to the organization's technical and operational domains. He is responsible for overseeing critical aspects such as process development, process scale-up, technology transfer, cGMP manufacturing, and regulatory submissions for biologic drugs.
Luca Di Noto's Role at Portola Pharmaceuticals
Before joining Jasper Therapeutics, Luca Di Noto spent five years at Portola Pharmaceuticals as the Head of Drug Substance Manufacturing. During his tenure, he oversaw the Andexxa program, playing an instrumental role in its progress. He was crucial in building a robust manufacturing program, developing a comprehensive global contract manufacturing network strategy, and obtaining successful approval for the second-generation version of Andexxa in both the United States and Europe.
Experience at Alexion Pharmaceuticals
Luca Di Noto has also worked at Alexion Pharmaceuticals, where he was involved in developing processes for many of the company's lead candidate drugs. His contributions spanned both early and late stages of drug development, showcasing his versatility and expertise in process development.
Early Career at National Institutes of Health
Luca Di Noto began his career at the National Institutes of Health (NIH) as a Research Fellow. He worked at the National Heart, Lung, and Blood Institute, gaining valuable experience and laying the foundation for his subsequent roles in the pharmaceutical industry.